Rising Incidence of Obesity & Increasing Demand for Sleeve Gastrectomy Drive the Global Bariatric (Obesity) Surgical Devices Market

Growing incidence of obesity among adults and children, improved success rate of laparoscopic surgeries, better reimbursement coverage, and technological advancements are poised to drive the global market for Bariatric (Obesity) Surgical Devices to reach US$2 billion by 2024.

Surgical intervention for obesity treatment is mainly through the established methods of Roux-en-Y Gastric Bypass (RYGB), Adjustable Gastric Banding (AGB), and Sleeve Gastrectomy (SG). Laparoscopy is a key trend pervading the bariatric surgery domain. Over the last decade, bariatric surgeries have been increasingly performed by laparoscopic techniques. While traditional bariatric procedures are performed through a midline incision on the upper abdomen and instrumental retraction of viscera to expose the target area, laparoscopic surgeries usually involve up to 5 small incisions and creation of pneumoperitoneal space between abdominal wall and viscera. Compared to open surgery, laparoscopic surgery is associated with reduced length of hospitalization and lower hospital charges, reduced infection and post-operative pain, faster recovery, and reduced post-operative mortality as well. Reported incidences of cardiac arrhythmia, blood transfusion, sepsis, pulmonary embolism, and gastrointestinal leaks were also fewer with laparoscopic RYGB when compared to open RYGB.

RYGB is considered to be the gold standard of bariatric surgeries. In this surgery, the stomach is divided into a small upper pouch and a larger lower pouch; the intestine is rerouted and connected to the upper pouch. The stomach size is reduced by cross-stapling the upper section of the stomach and subsequently separating the proximal and distal sections. The new stomach pouch is then directly attached to the small intestine through a “Roux limb”. This procedure reduces the amount of food that can be eaten and absorbed, by by-passing a large section of the stomach and intestines. However, symptoms such as pain and nausea may arise especially when high-energy food is ingested, because food directly reaches the jejunum after ingestion. Behavioural therapy and diet monitoring is therefore vital after the surgery.

Adjustable Gastric Banding (AGB) is the least invasive method which is also reversible and is usually performed in mid-level obese patients and in older patients. Laparoscopic method is increasingly used for this surgery. A band is placed around the upper part of the stomach and connected to a port beneath the skin. Saline solution is added or removed through the port to inflate or deflate the band respectively to control the rate of passage of food into the stomach. Slowing down the rate of passage of food causes a feeling of satiety and therefore reduced caloric intake of food. Sleeve Gastrectomy (SG) procedure is rapidly overtaking the RYGB and AGB as the bariatric surgery of choice. Though initially meant to be the first stage of biliopancreatic diversion (BPD) process, SG later evolved into a standalone procedure because several patients lost enough weight with only this procedure without the need for any further surgery. In this procedure, a section of the stomach is removed to leave just a sleeve-like tube with reduced size. This leads to faster onset of fullness and reduced food intake. Both gastric bypass and SG procedures use surgical staplers as the primary tool. Therefore, large suppliers of surgical staplers including Ethicon (J&J) and Medtronic are in favour of these procedures.

As stated by the new market research report on Bariatric (Obesity) Surgical Devices, the United States represents the largest regional market worldwide supported by a large base of obese population and easy availability and access to advanced healthcare services. Developing economies present strong opportunities for future growth led by growing number of overweight people, increasing prevalence of diabetes, improving healthcare infrastructure, and increased per capita healthcare spends. Led by China and India, Asia-Pacific is forecast to record the fastest CAGR of 14.4% over the analysis period.

Major players in the market include Apollo Endosurgery Inc., Agency for Medical Innovations GmbH, Bariatric Solutions GmBH, Cousin Biotech, Medtronic Plc, Ethicon US LLC, Helioscopie SA, and Médical Innovation Développement.

The research report titled “Bariatric (Obesity) Surgical Devices: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, and strategic industry activities of major companies worldwide. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific, Latin America, and Rest of World. The US market for Bariatric (Obesity) Surgical Devices is analyzed by the segments - Gastric Bypass, Gastric Banding, and Sleeve Gastrectomy.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

For cutting edge analyst reviews on top industries

Follow us on Twitter; Connect with us on LinkedIn; Follow us on Medium